N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

References

Page 1

	Year	Citations
Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach Elizabeth R. DeLong, David M. DeLong, Daniel L. Clarke‐Pearson Biometrics EngineeringNew TestsGeneralizability TheoryStatistical FoundationDiagnosis	1988	21.5K
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, New England Journal of Medicine	2009	11.1K
Apixaban versus Warfarin in Patients with Atrial Fibrillation Christopher B. Granger, John H. Alexander, John J.V. McMurray, New England Journal of Medicine	2011	8.8K
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Philip A. Wolf, Robert D. Abbott, W B Kannel Stroke HypertensionHeart FailureCerebrovascular DiseasePreventive CardiologyAcute Myocardial Infarction	1991	7.4K
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters, CHEST Journal ThrombosisVenous ThrombosisCardiovascular EpidemiologyIschemic StrokeCardiovascular Disease	2009	6.6K
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond Michael J. Pencina, Ralph B. D' Agostino, Ralph B. D' Agostino, Statistics in Medicine	2007	6.2K
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) European Heart Journal	2010	5.8K
Impact of Atrial Fibrillation on the Risk of Death Emelia J. Benjamin, Philip A. Wolf, Ralph B. D’Agostino, Circulation	1998	4.6K
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat, CHEST Journal Acute Myocardial InfarctionThrombosisStrokeBleeding DisorderPublic Health	2010	4.4K
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death Thomas J. Wang, Martin G. Larson, Daniel Levy, New England Journal of Medicine HypertensionPrognostic SignificanceCardiovascular FunctionCardiovascular ToxicityDiastolic Function	2004	1.5K

Page 1